Feb. 08 2018 |
|
Malvinder Singh
Promoter |
Fortis Healthcare Ltd.
India |
resigned from the directorship of the company just over a week after the Delhi High Court allowed the enforcement of a Rs 3,500-crore arbitration award that Japanese drugmaker Daiichi Sankyo had won. |
Resigned |
|
Feb. 08 2018 |
|
Shivinder Singh
Promoter |
Fortis Healthcare Ltd.
India |
resigned from the directorship of the company just over a week after the Delhi High Court allowed the enforcement of a Rs 3,500-crore arbitration award that Japanese drugmaker Daiichi Sankyo had won. |
Resigned |
|
May. 21 2018 |
|
Harpal Singh
Director |
Fortis Healthcare Ltd.
India |
|
Resigned |
|
May. 21 2018 |
|
Tejinder Singh Shergill
Director |
Fortis Healthcare Ltd.
India |
|
Resigned |
|
May. 21 2018 |
|
Sabina Vaisoha
Director |
Fortis Healthcare Ltd.
India |
|
Resigned |
|
Aug. 30 2018 |
Sep. 30 2018 |
Gagandeep Singh Bedi
CFO |
Fortis Healthcare Ltd.
India |
|
Resigned |
|
Nov. 08 2018 |
|
Bhavdeep Singh
CEO |
Fortis Healthcare Ltd.
India |
|
Resigned |
|
Dec. 29 2018 |
Dec. 28 2018 |
Deloitte Haskins
Statutory Auditor |
Fortis Healthcare Ltd.
India |
|
Resigned |
|